Discussion forum

Research and Clinical Forums

Volumn 19, Issue 3, 1997, Pages 39-46

  Walter, D S ^a   Chapleo, C B ^a   Reisinger, M ^b  

^a Reckitt & Colman   (United Kingdom)

^b Europ Opiate Addict Treatm Assoc   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; PARTIAL AGONIST;

DETOXIFICATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAINTENANCE THERAPY; OPIATE ADDICTION; PREGNANCY; REVIEW;

EID: 0030817499     PISSN: 01433083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. LING, W., WESSON, D.R. and KLETT, C.J. A multicentre clinical trial of buprenorphine in treatment of opiate dependence. Submitted.
2. BRIDGE, P., Long term extension of a multicentre clinical trial of buprenorphine in treatment of opiate dependence. Reckitt & Colman Products Ltd., data on file.
3. STRAIN, E.G., STITZER, M.L., LIEBSON, I.A. and BIGELOW, G.E. An out-patient trial of methadone versus buprenorphine in the treatment of combined opiod and cocaine dependence. In: Problems of drug dependence. N.I.D.A. Research Monograph Series, (Ed. L.S. Harris), 1994; 141: pp 141.
4. JASINSKI, D.R., PEVNICK, J.S. and GRIFFITH, J.D. Human pharmacology and abuse potential of the analgesic buprenorphine. Arch. Gen. Psychiatry, 1978; 35: 501-516.
5. BICKEL, W.K., STITZER, M.L., BIGELOW, G.E., LIEBSON, I.A., JASINSKI, D.R. and JOHNSON, R.E. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin. Pharmacol. Ther., 1988; 48: 72-78.
6. JOHNSON, R.E., JAFFE, J.H. and FUDALA, P.J. A controlled trial of buprenorphine treatment for opioid dependence. J. Am. Med .Assoc., 1992; 267: 2750-2755.
7. FUDALA, P.J., JAFFE, J.H., DAX, E.M. and JOHNSON, R.E. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioural effects of daily and alternate-day administration and abrupt withdrawal. Clin. Pharmacol. Ther., 1990; 47: 525-534.
8. AMASS, L., BICKEL, W.K., HIGGINS, S.T. and HUGHES, J.R. A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification. J. Addict. Dis., 1994; 13: 33-45.
9. CHESKIN, L.J., FUDALA, P.J. and JOHNSON, R.E. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Drug and Alcohol Dependence, 1994; 36: 115-121.
10. NIGRAM, A.K., RAY, R. and TRIPATHI, B.M. Buprenorphine in opiate withdrawal: a comparison with clonidine. J. Substance Abuse Treat., 1993; 10: 391-394.
11. JOHNSON, R.E. EISSENBERG, T., STITZER, M.L., STRAIN, E.C., LIEBSON, I.A. and BIGELOW, G.E. Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing. Drug and Alcohol Dependence, 1995; 40: 27-35.
12. AMASS, L., BICKEL, W.K., HIGGINS, S.T. and BADGER, G.J. Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sciences, 1994; 54: 1215-1228.
13. BICKEL, W.K., AMASS, L., CREAN, J.P. and HIGGINS, S.T. Triple buprenorphine maintenance doses maintain opioid-dependent outpatients for 72 hours with minimal withdrawal. In: Problems of drug dependence 1995, N.I.D.A. Research Monograph Series, 1995; 153: pp 161.
14. BICKEL, W.K., PETRY, N.M. and TZANIS, E. The limits of multiple-day dosing with buprenorphine? Quintuple doses. College on Problems of Drug Dependence, 58th Annual Scientific Meeting, 1996.
15. WALSH, S.L., PRESTON, K.L., STITZER, M.L., CONE, E.J. and BIGLOW, G.E. Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin. Pharmacol. Ther., 1994; 55: 569-580.
16. LEWIS, J.W., RANCE, M.J and SANGER, D.J. The pharmacology and abuse potential of buprenorphine: a new antagonistic analgesic. Adv. Subst. Abuse, 1983; 3: 103-154.
17. Unpublished data. Reckitt and Colman Products Ltd, data on file.
18. REISINGER, M. Treatment of four pregnant heroin addicts with buprenorphine: history and outcome. Presented at College on Problems of Drug Dependence, 57th Annual Scientific Meeting; Scotsdale, Arizona, 1995: Abstract pp 116.